Medicine and Dentistry
Patient
100%
Myelodysplastic Syndrome
69%
Transplantation
50%
Reduced Intensity Conditioning
48%
Allogeneic Hematopoietic Stem Cell Transplantation
41%
Secondary Acute Myeloid Leukemia
27%
Stem Cell Therapy
21%
Donor
21%
Thymocyte Antibody
16%
International Prognostic Scoring System
16%
T Cell
15%
Acute Myeloid Leukemia
13%
Donor Lymphocyte Infusion
13%
Intensive Care Unit
13%
Ferritin
13%
Hematologic Malignancy
13%
Chronic Myelomonocytic Leukemia
13%
Experience
13%
Bone Marrow
13%
Hematopoietic Stem Cell Transplantation
13%
Myeloma
11%
Overall Survival
10%
Disease
8%
Hematopoietic Cell
7%
Hazard Ratio
7%
Multivariate Analysis
7%
Therapeutic Procedure
7%
Cumulative Incidence
5%
Volunteer
5%
Immunology and Microbiology
Transplant Procedure
43%
Graft-Versus-Host Disease
32%
Bone Marrow
8%
Engraftment
6%